268 related articles for article (PubMed ID: 20152719)
1. Uptake of 3-[125I]iodo-alpha-methyl-L-tyrosine into colon cancer DLD-1 cells: characterization and inhibitory effect of natural amino acids and amino acid-like drugs.
Shikano N; Ogura M; Okudaira H; Nakajima S; Kotani T; Kobayashi M; Nakazawa S; Baba T; Yamaguchi N; Kubota N; Iwamura Y; Kawai K
Nucl Med Biol; 2010 Feb; 37(2):197-204. PubMed ID: 20152719
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of 125I-3-iodo-alpha-methyl-L-tyrosine uptake in Chinese hamster ovary (CHO-K1) cells by tyrosine esters.
Shikano N; Ogura M; Sagara J; Nakajima S; Kobayashi M; Baba T; Yamaguchi N; Iwamura Y; Kubota N; Kawai K
Nucl Med Biol; 2010 Feb; 37(2):189-96. PubMed ID: 20152718
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of 3-[125I]iodo-alpha-methyl-L-tyrosine, a tumor imaging agent, after probenecid loading in mice implanted with colon cancer DLD-1 cells.
Nakajima S; Shikano N; Kotani T; Ogura M; Nishii R; Yoshimoto M; Yamaguchi N; Iwamura Y; Kubota N; Ishikawa N; Kawai K
Nucl Med Biol; 2007 Nov; 34(8):1003-8. PubMed ID: 17998105
[TBL] [Abstract][Full Text] [Related]
4. Characterization of 3-[(123)I]iodo-L-alpha-methyl tyrosine transport in astrocytes of neonatal rats.
Kopka K; Riemann B; Friedrich M; Winters S; Halfter H; Weckesser M; Stögbauer F; Ringelstein EB; Schober O
J Neurochem; 2001 Jan; 76(1):97-104. PubMed ID: 11145982
[TBL] [Abstract][Full Text] [Related]
5. Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine.
Langen KJ; Mühlensiepen H; Holschbach M; Hautzel H; Jansen P; Coenen HH
J Nucl Med; 2000 Jul; 41(7):1250-5. PubMed ID: 10914918
[TBL] [Abstract][Full Text] [Related]
6. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
Wiriyasermkul P; Nagamori S; Tominaga H; Oriuchi N; Kaira K; Nakao H; Kitashoji T; Ohgaki R; Tanaka H; Endou H; Endo K; Sakurai H; Kanai Y
J Nucl Med; 2012 Aug; 53(8):1253-61. PubMed ID: 22743251
[TBL] [Abstract][Full Text] [Related]
7. Characterization of 3-[125I]iodo-alpha-methyl-L-tyrosine transport via human L-type amino acid transporter 1.
Shikano N; Kanai Y; Kawai K; Ishikawa N; Endou H
Nucl Med Biol; 2003 Jan; 30(1):31-7. PubMed ID: 12493540
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization and molecular expression of large neutral amino acid transporter (LAT1) in human prostate cancer cells.
Patel M; Dalvi P; Gokulgandhi M; Kesh S; Kohli T; Pal D; Mitra AK
Int J Pharm; 2013 Feb; 443(1-2):245-53. PubMed ID: 23270998
[TBL] [Abstract][Full Text] [Related]
9. Transcellular transport of radioiodinated 3-iodo-alpha-methyl-L-tyrosine across monolayers of kidney epithelial cell line LLC-PK1.
Shikano N; Kawai K; Nakajima S; Kubodera A; Kubota N; Ishikawa N; Saji H
Ann Nucl Med; 2004 May; 18(3):227-34. PubMed ID: 15233284
[TBL] [Abstract][Full Text] [Related]
10. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells.
Kim SG; Kim HH; Kim HK; Kim CH; Chun HS; Kanai Y; Endou H; Kim DK
Anticancer Res; 2006; 26(3A):1989-96. PubMed ID: 16827134
[TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of the influx of 3-[125I]iodo-L-alpha-methyltyrosine and 2-[125I]iodo-L-tyrosine into U266 human myeloma cells: evidence for system T transport.
Lahoutte T; Caveliers V; Dierickx L; Vekeman M; Everaert H; Mertens J; Bossuyt A
Nucl Med Biol; 2001 Feb; 28(2):129-34. PubMed ID: 11295423
[TBL] [Abstract][Full Text] [Related]
12. Involvement of LAT1 and LAT2 in the high- and low-affinity transport of L-leucine in human retinal pigment epithelial cells (ARPE-19 cells).
Yamamoto A; Akanuma S; Tachikawa M; Hosoya K
J Pharm Sci; 2010 May; 99(5):2475-82. PubMed ID: 19890975
[TBL] [Abstract][Full Text] [Related]
13. Relationship between thyroid hormone transport and neutral amino acid transport in JAR human choriocarcinoma cells.
Prasad PD; Leibach FH; Mahesh VB; Ganapathy V
Endocrinology; 1994 Feb; 134(2):574-81. PubMed ID: 8299556
[TBL] [Abstract][Full Text] [Related]
14. The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier.
Kageyama T; Nakamura M; Matsuo A; Yamasaki Y; Takakura Y; Hashida M; Kanai Y; Naito M; Tsuruo T; Minato N; Shimohama S
Brain Res; 2000 Oct; 879(1-2):115-21. PubMed ID: 11011012
[TBL] [Abstract][Full Text] [Related]
15. Characterization of uptake of 3-[(131)I]iodo-alpha-methyl-L-tyrosine in human monocyte-macrophages.
Prante O; Deichen JT; Hocke C; Kuwert T
Nucl Med Biol; 2004 Apr; 31(3):365-72. PubMed ID: 15028249
[TBL] [Abstract][Full Text] [Related]
16. Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2.
Simmons-Willis TA; Koh AS; Clarkson TW; Ballatori N
Biochem J; 2002 Oct; 367(Pt 1):239-46. PubMed ID: 12117417
[TBL] [Abstract][Full Text] [Related]
17. Uptake mechanisms of L-3-[125I]iodo-alpha-methyl-tyrosine in a human small-cell lung cancer cell line: comparison with L-1.
Jager PL; de Vries EG; Piers DA; Timmer-Bosscha H
Nucl Med Commun; 2001 Jan; 22(1):87-96. PubMed ID: 11233558
[TBL] [Abstract][Full Text] [Related]
18. Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats.
Samnick S; Richter S; Romeike BF; Heimann A; Feiden W; Kempski O; Kirsch CM
Eur J Nucl Med; 2000 Oct; 27(10):1543-51. PubMed ID: 11083545
[TBL] [Abstract][Full Text] [Related]
19. Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cells.
Oka S; Okudaira H; Yoshida Y; Schuster DM; Goodman MM; Shirakami Y
Nucl Med Biol; 2012 Jan; 39(1):109-19. PubMed ID: 21958853
[TBL] [Abstract][Full Text] [Related]
20. Isoform selectivity of 3-125I-iodo-alpha-methyl-L-tyrosine membrane transport in human L-type amino acid transporters.
Shikano N; Kanai Y; Kawai K; Inatomi J; Kim DK; Ishikawa N; Endou H
J Nucl Med; 2003 Feb; 44(2):244-6. PubMed ID: 12571216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
